Global Burden of 5 Major Types Of Gastrointestinal Cancer.

BACKGROUND & AIMS There were an estimated 4.8 million new cases of gastrointestinal (GI) cancers and 3.4 million related deaths, worldwide, in 2018. GI cancers account for 26% of the global cancer incidence and 35% of all cancer-related deaths. We investigated the global burden from the 5 major GI cancers as well as geographic and temporal trends in cancer-specific incidence and mortality. METHODS Data on primary cancers of the esophagus, stomach, colorectum, liver, and pancreas were extracted from the GLOBOCAN database for the year 2018, as well as from the Cancer Incidence in 5 Continents series, and the World Health Organization mortality database from 1960 onward. Age-standardized incidence and mortality rates were calculated by sex, country, and level of human development. RESULTS We observed geographic and temporal variations in incidence and mortality for all 5 types of GI cancers. Esophageal, gastric, and liver cancers were more common in Asia than in other parts of the world, whereas of the burden from colorectal and pancreatic cancers was highest in Europe and North America. There was a uniform decrease in gastric cancer incidence but an increasing incidence of colorectal cancer in formerly low-incidence regions over the studied time period. We found slight increases in incidence of liver and pancreatic cancer in some high-income regions. CONCLUSIONS Although the incidence of some GI cancer types has decreased, this group of malignancies continues to pose major challenges to public health. Primary and secondary prevention measures are important for controlling these malignancies-most importantly reducing consumption of tobacco and alcohol, obesity control, immunizing populations against hepatitis B virus infection, and screening for colorectal cancer.

[1]  B. Teh,et al.  Cholangiocarcinoma , 2021, Nature Reviews Disease Primers.

[2]  J. Ferlay,et al.  International trends in hepatocellular carcinoma incidence, 1978–2012 , 2020, International journal of cancer.

[3]  J. Ferlay,et al.  Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. , 2019, The Lancet. Global health.

[4]  A. Gavin,et al.  Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. , 2019, The Lancet. Oncology.

[5]  T. H. Nguyen,et al.  The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[6]  T. H. Nguyen,et al.  The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[7]  Eyal Oren,et al.  The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[8]  J. Ferlay,et al.  Changes in colorectal cancer incidence in seven high-income countries: a population-based study. , 2019, The lancet. Gastroenterology & hepatology.

[9]  K. McColl What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? , 2019, Journal of Gastroenterology.

[10]  V. Zadnik,et al.  Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years , 2019, Gut.

[11]  K. McGlynn,et al.  The Changing Epidemiology of Primary Liver Cancer , 2019, Current Epidemiology Reports.

[12]  R. Malekzadeh,et al.  Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. , 2019, Gastroenterology.

[13]  E. Lee,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016 , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[14]  A. Jemal,et al.  Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. , 2019, The Lancet. Public health.

[15]  J. Ferlay,et al.  Global cancer incidence in older adults, 2012 and 2035: A population‐based study , 2018, International journal of cancer.

[16]  E. Oren,et al.  Race/Ethnicity-, Socioeconomic Status-, and Anatomic Subsite-Specific Risks for Gastric Cancer. , 2018, Gastroenterology.

[17]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[18]  P. Schrotz-King,et al.  Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study , 2018, BMC Medicine.

[19]  S. Smith,et al.  Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux , 2018, BMC Cancer.

[20]  C. Hamashima Update version of the Japanese Guidelines for Gastric Cancer Screening. , 2018, Japanese journal of clinical oncology.

[21]  P. Rosenberg,et al.  The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites , 2018, Journal of the National Cancer Institute.

[22]  T. Matsuda,et al.  Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs , 2018, Annals of Cancer Epidemiology.

[23]  Ning Wang,et al.  Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. , 2018, The Lancet. Global health.

[24]  K. Straif,et al.  The IARC Perspective on Colorectal Cancer Screening. , 2018, The New England journal of medicine.

[25]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[26]  C. Mathew,et al.  The African Esophageal Cancer Consortium: A Call to Action , 2018, Journal of global oncology.

[27]  C. Abnet,et al.  Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.

[28]  W. Ridtitid,et al.  Liver Fluke-Associated Biliary Tract Cancer , 2017, Gut and liver.

[29]  R. Malekzadeh,et al.  Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project , 2016, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[30]  Ahmedin Jemal,et al.  Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States , 2018, CA: a cancer journal for clinicians.

[31]  A. Wolk,et al.  Alcohol consumption and gastric cancer risk—A pooled analysis within the StoP project consortium , 2017, International journal of cancer.

[32]  S. Ng,et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.

[33]  F. Bray,et al.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030 , 2017, The American Journal of Gastroenterology.

[34]  Philip S Rosenberg,et al.  Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.

[35]  F. Bray,et al.  Assessing global transitions in human development and colorectal cancer incidence , 2017, International journal of cancer.

[36]  I. Choi,et al.  Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. , 2017, Gastroenterology.

[37]  M. Mohammadian,et al.  Physical Activity and Colorectal Cancer , 2016, Iranian journal of public health.

[38]  E. Giovannucci,et al.  Association of Physical Activity by Type and Intensity With Digestive System Cancer Risk. , 2016, JAMA oncology.

[39]  E. Giovannucci,et al.  Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States. , 2016, JAMA oncology.

[40]  J. Ferlay,et al.  More deaths from pancreatic cancer than breast cancer in the EU by 2017 , 2016, Acta oncologica.

[41]  A. Fournier,et al.  Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. , 2016, JAMA internal medicine.

[42]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[43]  A. Thrift The epidemic of oesophageal carcinoma: Where are we now? , 2016, Cancer epidemiology.

[44]  Tran Quoc Bao,et al.  Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants , 2016, The Lancet.

[45]  J. Kleeff,et al.  Pancreatic cancer , 1988, Nature Reviews Disease Primers.

[46]  Kurt Straif,et al.  Carcinogenicity of consumption of red and processed meat. , 2015, The Lancet. Oncology.

[47]  E. Kuipers,et al.  Colorectal cancer screening: a global overview of existing programmes , 2015, Gut.

[48]  Zhi-Feng Chen,et al.  Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  J. Ferlay,et al.  Global patterns of cardia and non-cardia gastric cancer incidence in 2012 , 2015, Gut.

[50]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[51]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[52]  R. Hunt,et al.  Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.

[53]  M. Dinis-Ribeiro,et al.  Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies , 2013, Helicobacter.

[54]  India,et al.  Cancer Incidence in Five Continents Vol. X , 2013 .

[55]  N. Freedman,et al.  Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium , 2012, International journal of epidemiology.

[56]  R. Fitzgerald,et al.  Screening for oesophageal cancer , 2012, Nature Reviews Clinical Oncology.

[57]  D. Parkin,et al.  Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. , 2012, Cancer epidemiology.

[58]  K. Straif,et al.  Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  P. Rosenberg,et al.  Divergent trends for gastric cancer incidence by anatomical subsite in US adults , 2011, Gut.

[60]  Seyed Mohsen Mousavi,et al.  Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[61]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[62]  P. Maisonneuve,et al.  Smoking and colorectal cancer: a meta-analysis. , 2008, JAMA.

[63]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[64]  R. Malekzadeh,et al.  Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. , 2007, World journal of gastroenterology.

[65]  M. Blaser,et al.  Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. , 2006, Journal of the National Cancer Institute.

[66]  R. Malekzadeh,et al.  Esophageal cancer in northeastern Iran. , 2005, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[67]  E. Riboli,et al.  Meat consumption and colorectal cancer risk: Dose‐response meta‐analysis of epidemiological studies , 2002, International journal of cancer.

[68]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[69]  E. Wynder,et al.  The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.

[70]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.